HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Johannes Oldenburg Selected Research
Johannes Oldenburg Research Topics
Disease
110
Hemophilia A (Haemophilia)
04/2024 - 06/2002
81
Hemorrhage
04/2024 - 11/2002
18
Thrombosis (Thrombus)
02/2024 - 03/2006
13
Hemophilia B (Haemophilia B)
01/2024 - 09/2003
9
Thrombophilia
02/2024 - 08/2012
7
Thrombotic Microangiopathies
12/2023 - 01/2017
7
COVID-19
11/2023 - 03/2021
7
Infections
03/2021 - 01/2009
6
Venous Thromboembolism
01/2024 - 01/2005
6
Type 3 von Willebrand Disease
01/2023 - 11/2019
6
von Willebrand Diseases (von Willebrand's Disease)
01/2022 - 07/2004
5
1 Combined Deficiency Of Vitamin K-Dependent Clotting Factors
01/2022 - 08/2004
5
Type 2 Combined Deficiency Of Vitamin K-Dependent Clotting Factors
08/2015 - 02/2004
5
Coumarin Resistance
10/2013 - 02/2004
4
Activated Protein C Resistance (APC Resistance)
01/2024 - 01/2014
4
Neoplasms (Cancer)
01/2024 - 01/2019
4
Factor XIII Deficiency
10/2023 - 06/2010
4
Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 01/2005
3
Wounds and Injuries (Trauma)
01/2022 - 01/2014
3
Joint Diseases (Joint Disease)
11/2021 - 03/2015
3
Thrombocytopenia (Thrombopenia)
10/2021 - 10/2016
3
Metrorrhagia (Spotting)
05/2021 - 01/2017
3
Hypersensitivity (Allergy)
06/2018 - 02/2008
3
Autoimmune Diseases (Autoimmune Disease)
01/2018 - 04/2006
2
Hemolysis
04/2024 - 01/2021
2
Injection Site Reaction
12/2023 - 01/2017
2
Body Weight (Weight, Body)
01/2023 - 01/2018
2
Thrombotic Thrombocytopenic Purpura
09/2022 - 01/2022
2
Mast Cell Activation Disorders (Mast-Cell Disease)
08/2021 - 01/2015
2
Inborn Genetic Diseases (Disease, Hereditary)
01/2021 - 06/2005
2
Vitamin K Deficiency
01/2021 - 10/2014
2
Thromboembolism
01/2017 - 08/2015
2
Hydatidiform Mole (Molar Pregnancy)
01/2015 - 10/2014
Drug/Important Bio-Agent (IBA)
77
Factor VIII (Coagulation Factor VIII)
IBA
04/2024 - 06/2002
25
Blood Coagulation Factors (Coagulation Factor)
IBA
12/2022 - 11/2002
23
emicizumab
IBA
01/2024 - 01/2017
18
Vitamin K
FDA Link
04/2022 - 02/2004
16
Proteins (Proteins, Gene)
FDA Link
03/2024 - 01/2004
16
Thrombin
FDA Link
02/2024 - 05/2012
15
Antibodies
IBA
03/2024 - 04/2006
14
Anticoagulants
IBA
02/2024 - 02/2004
13
von Willebrand Factor
IBA
01/2023 - 10/2012
11
Protein C
IBA
02/2024 - 11/2002
11
Factor IX (Coagulation Factor IX)
FDA Link
Generic
01/2024 - 09/2003
10
Prothrombin (Factor II)
IBA
01/2024 - 01/2017
8
Factor XIII (Coagulation Factor XIII)
IBA
10/2023 - 06/2010
6
Heme (Haem)
IBA
04/2024 - 01/2019
6
Autoantibodies
IBA
12/2023 - 04/2009
5
recombinant factor VIII N8
IBA
02/2024 - 01/2017
5
Hemostatics (Antihemorrhagics)
IBA
01/2024 - 01/2016
5
glutamyl carboxylase (gamma-glutamyl carboxylase)
IBA
01/2022 - 08/2004
5
Antigens
IBA
01/2020 - 01/2004
5
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 09/2011
4
Immunoglobulin G (IgG)
IBA
03/2024 - 11/2008
4
Vaccines
IBA
09/2022 - 06/2021
4
Antiviral Agents (Antivirals)
IBA
01/2018 - 01/2009
4
Antithrombins
IBA
01/2018 - 08/2011
4
coumarin
IBA
11/2008 - 02/2004
3
Fibrinogen (Factor I)
FDA Link
04/2024 - 01/2017
3
Immunoglobulins (Immunoglobulin)
IBA
03/2024 - 12/2009
3
Factor VIIa (Activated Factor VII)
IBA
02/2024 - 01/2022
3
Biomarkers (Surrogate Marker)
IBA
02/2024 - 10/2016
3
Albumins
IBA
01/2024 - 01/2016
3
MicroRNAs (MicroRNA)
IBA
01/2024 - 01/2020
3
6-pyruvoyltetrahydropterin synthase (PTPS)
IBA
10/2023 - 01/2019
3
simoctocog alfa (Nuwiq)
IBA
10/2023 - 01/2019
3
factor IX Fc fusion protein
IBA
07/2023 - 01/2017
3
Isoantibodies
IBA
01/2023 - 02/2015
3
apixaban
IBA
05/2022 - 01/2020
3
Rivaroxaban
IBA
05/2022 - 01/2020
3
Messenger RNA (mRNA)
IBA
01/2022 - 04/2006
3
Heparin (Liquaemin)
FDA Link
Generic
06/2021 - 01/2015
3
Warfarin (Coumadin)
FDA Link
Generic
01/2021 - 02/2004
3
Platelet Membrane Glycoproteins
IBA
01/2020 - 09/2011
3
nonacog beta pegol
IBA
11/2018 - 12/2014
3
Protein S
IBA
01/2017 - 11/2002
3
Vitamin K Epoxide Reductases
IBA
10/2014 - 09/2006
3
N- methyl- N- (1- phenylethyl)- 2- propynylamine
IBA
02/2014 - 12/2009
3
Enzymes
IBA
10/2013 - 06/2006
3
Interleukin-10 (Interleukin 10)
IBA
04/2010 - 04/2006
2
Valoctocogene Roxaparvovec
IBA
04/2024 - 01/2023
2
Factor VII (Proconvertin)
IBA
02/2024 - 01/2012
2
recombinant FVIIa (rFVIIa)
FDA Link
02/2024 - 01/2022
2
Recombinant Fusion Proteins
IBA
01/2024 - 01/2016
2
Vitamin D
FDA Link
Generic
06/2023 - 10/2006
2
thiamine triphosphorate (TTP)
IBA
09/2022 - 01/2022
2
RNA (Ribonucleic Acid)
IBA
03/2022 - 05/2021
2
Matrix Gla Protein
IBA
01/2022 - 10/2014
2
COVID-19 Vaccines
IBA
01/2022 - 06/2021
2
concizumab
IBA
01/2022 - 11/2019
2
Monoclonal Antibodies
IBA
01/2021 - 12/2019
2
factor VIII-Fc fusion protein
IBA
05/2020 - 01/2016
2
Antiphospholipid Antibodies
IBA
01/2020 - 05/2012
2
Factor IXa (Coagulation Factor IXa)
IBA
12/2019 - 01/2017
2
Interleukin-6 (Interleukin 6)
IBA
12/2018 - 01/2012
Therapy/Procedure
36
Therapeutics
04/2024 - 09/2003
3
Transcatheter Aortic Valve Replacement
10/2021 - 10/2016
3
Injections
01/2019 - 01/2017
2
Conservative Treatment
11/2021 - 03/2017
2
Immunotherapy
01/2021 - 01/2021